PeptiDex
Peptide Research Index
Research-backed
Peptide Research Index
⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use
"The Wolverine Stack"
Accelerated injury healing, tissue repair, reduced inflammation, enhanced recovery
BPC-157 targets local tissue repair via angiogenesis and growth factors, while TB-500 provides systemic anti-inflammatory and cell migration support. Together they deliver complementary healing pathways — BPC works at the injury site, TB-500 works system-wide.
BPC-157 promotes angiogenesis and collagen deposition at injury sites via FAK-paxillin signaling. TB-500 upregulates actin for cell migration and wound healing systemically. The combination creates a dual-pathway healing response significantly more effective than either peptide alone.
Typical Ratio: BPC-157 500mcg + TB-500 2.5mg per dose
Common protocol: BPC-157 250-500mcg + TB-500 2-5mg, injected SubQ 1-2x daily. BPC near injury site, TB-500 anywhere. Cycle 4-12 weeks.
Week 1
Reduced inflammation and pain at injury site; improved mobility
Weeks 2–4
Significant tissue repair; noticeable reduction in swelling and stiffness
Months 2–3
Substantial healing of tendons, ligaments, and soft tissue injuries
Long-term
Complete functional recovery for most acute/subacute injuries
Both peptides have excellent safety profiles individually. The combination is the most widely used peptide stack. Not FDA-approved. Research-only.